Quotient Bioresearch Overview
- Year Founded
-
1940
- Status
-
Acquired/Merged
- Employees
-
697
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
4
Quotient Bioresearch General Information
Description
Operator of a contract research organization (CRO) in the life sciences sector. The company focuses on integrating radiochemistry and metabolism. It provides services related to radiochemistry, drug metabolism and E-fate, which it tailors to pharmaceutical, biotechnology, agrochemical and chemical sponsors worldwide, using technologies underpinned by scientific, chemical and biological expertise.
Contact Information
Website
www.quotientbioresearch.comCorporate Office
- Newmarket Road
- Fordham CB7 5WW
- England, United Kingdom
Corporate Office
- Newmarket Road
- Fordham CB7 5WW
- England, United Kingdom
Quotient Bioresearch Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quotient Bioresearch Comparisons
Industry
Financing
Details
Quotient Bioresearch Competitors (19)
One of Quotient Bioresearch’s 19 competitors is Reliance Life Sciences, a Corporation company based in Navi Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Reliance Life Sciences | Corporation | Navi Mumbai, India | ||||
| SpiroChem | Venture Capital-Backed | Basel, Switzerland | ||||
| Syngene International | Formerly PE-Backed | Bangalore, India | ||||
| Exagen | Formerly VC-backed | Vista, CA | ||||
| Coriolis Pharma | Venture Capital-Backed | Martinsried, Germany |
Quotient Bioresearch Signals
Quotient Bioresearch Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quotient Bioresearch Investments & Acquisitions (4)
Quotient Bioresearch’s most recent deal was a Buyout/LBO with GE Healthcare (Amersham Radiolabeling Operations) for . The deal was made on 25-Jun-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GE Healthcare (Amersham Radiolabeling Operations) | 25-Jun-2009 | Buyout/LBO | Biotechnology | ||
| Quotient Sciences | 15-Dec-2008 | Buyout/LBO | BPO/Outsource Services | ||
| Alba Bioscience | 01-Aug-2007 | Merger/Acquisition | Pharmaceuticals | ||
| HFL Sport Science | 25-Jan-2007 | Merger/Acquisition | Laboratory Services (Healthcare) |
Quotient Bioresearch Exits (2)
Quotient Bioresearch’s most recent exit was on 15-Dec-2008 from Quotient Sciences. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Quotient Sciences | 15-Dec-2008 | Completed |
|
||
| HFL Sport Science | 25-Jan-2007 | Merger/Acquisition | Completed |
Quotient Bioresearch FAQs
-
When was Quotient Bioresearch founded?
Quotient Bioresearch was founded in 1940.
-
Where is Quotient Bioresearch headquartered?
Quotient Bioresearch is headquartered in Fordham, United Kingdom.
-
What is the size of Quotient Bioresearch?
Quotient Bioresearch has 697 total employees.
-
What industry is Quotient Bioresearch in?
Quotient Bioresearch’s primary industry is Biotechnology.
-
Is Quotient Bioresearch a private or public company?
Quotient Bioresearch is a Private company.
-
What is the current valuation of Quotient Bioresearch?
The current valuation of Quotient Bioresearch is .
-
What is Quotient Bioresearch’s current revenue?
The current revenue for Quotient Bioresearch is .
-
How much funding has Quotient Bioresearch raised over time?
Quotient Bioresearch has raised $65M.
-
Who are Quotient Bioresearch’s investors?
TA Associates Management has invested in Quotient Bioresearch.
-
Who are Quotient Bioresearch’s competitors?
Reliance Life Sciences, SpiroChem, Syngene International, Exagen, and Coriolis Pharma are some of the 19 competitors of Quotient Bioresearch.
-
When was Quotient Bioresearch acquired?
Quotient Bioresearch was acquired on 04-Feb-2016.
-
Who acquired Quotient Bioresearch?
Quotient Bioresearch was acquired by Pharmaron.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process